Incidental chronic kidney disease in metabolic syndrome

Tzu Chi Medical Journal

Volumn 22, Issue 1, 2010, Pages 11-17

  Chou, Chu Lin ^a,b   Fang, Te Chao ^b,c  

^a HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Chronic kidney disease; Hyperinsulinemia; Insulin resistance; Metabolic syndrome; Renin angiotensin system

Indexed keywords

ENDOTHELIN 1; GROWTH FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SCLEROPROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; FIBROSING ALVEOLITIS; FOAM CELL; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID PEROXIDATION; MESANGIUM CELL; METABOLIC SYNDROME X; MICROANGIOPATHY; OXIDATIVE STRESS; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 77952485246     PISSN: 10163190     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1016-3190(10)60029-8     Document Type: Review

References (55)

1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288:2709-2716.
2. Chuang SY, Chen CH, Chou P Prevalence of metabolic syndrome in a large health check-up population in Taiwan. J Chin Med Assoc 2004, 67:611-620.
3. Chien KL, Hsu HC, Lee YT, Chen MF Renal function and metabolic syndrome components on cardiovascular and all-cause mortality. Atherosclerosis 2008, 197:860-867.
4. Kurella M, Lo JC, Chertow GM Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005, 16:2134-2140.
5. Reaven GM Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
6. Reaven GM, Ho H Sugar-induced hypertension in Sprague- Dawley rats. Am J Hypertens 1991, 4:610-614.
7. Tran LT, Yuen VG, McNeill JH The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem 2009, 332:145-159.
8. Lavau M, Fried SK, Susini C, Freychet P Mechanism of insulin resistance in adipocytes of rats fed a high-fat diet. J Lipid Res 1979, 20:8-16.
9. Ogihara T, Asano T, Ando K, et al. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes 2001, 50:573-583.
10. Wilkes JJ, DeForrest LL, Nagy LE Chronic ethanol feeding in a high-fat diet decreases insulin-stimulated glucose transport in rat adipocytes. Am J Physiol 1996, 271:E477-E484.
11. Chen CC, Li TC, Chang PC, et al. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism 2008, 57:544-548.
12. Ferrannini E, Balkau B, Coppack SW, et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007, 92:2885-2892.
13. Ren J, Kelley RO Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Obesity (Silver Spring) 2009, 17:1114-1123.
14. Ordovas JM, Corella D Metabolic syndrome pathophysiology: the role of adipose tissue. Kidney Int Suppl 2008, S10-S14.
15. Cooper SA, Whaley-Connell A, Habibi J, et al. Reninangiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 2007, 293:H2009-H2023.
16. Duan SZ, Usher MG, Mortensen RM PPARs: the vasculature, inflammation and hypertension. Curr Opin Nephrol Hypertens 2009, 18:128-133.
17. Tilg H, Moschen AR Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
18. Perin PC, Maule S, Quadri R Sympathetic nervous system, diabetes, and hypertension. Clin Exp Hypertens 2001, 23:45-55.
19. Beddhu S, Nigwekar SU, Ma X, Greene T Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease. Nephrol Dial Transplant 2009, 24:2482-2488.
20. Alberti KG, Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
21. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
22. Zimmet P, KG MMA, Serrano Rios M A new International Diabetes Federation worldwide definition of the metabolic syndrome: the rationale and the results. Rev Esp Cardiol 2005, 58:1371-1376.
23. Hung WW The role of statin in metabolic syndrome. Newsletter of the Taiwan Medical Association for the Study of Obesity 2008, 4:6-9.
24. Lawlor DA, Smith GD, Ebrahim S Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 2006, 49:41-48.
25. Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004, 140:167-174.
26. Rashidi A, Ghanbarian A, Azizi F Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol 2007, 2:976-983.
27. Ninomiya T, Kiyohara Y, Kubo M, et al. Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study. Am J Kidney Dis 2006, 48:383-391.
28. Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K Metabolic syndrome and chronic kidney disease in Okinawa, Japan. Kidney Int 2006, 69:369-374.
29. Tozawa M, Iseki C, Tokashiki K, et al. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 2007, 30:937-943.
30. Iseki K, Kohagura K, Sakima A, et al. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). Hypertens Res 2007, 30:55-62.
31. Zhang L, Zuo L, Wang F, et al. Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. Mayo Clin Proc 2007, 82:822-827.
32. Lucove J, Vupputuri S, Heiss G, North K, Russell M Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis 2008, 51:21-28.
33. Kawamoto R, Kohara K, Tabara Y, Miki T An association between metabolic syndrome and the estimated glomerular filtration rate. Intern Med 2008, 47:1399-1406.
34. Ryu S, Chang Y, Woo HY, et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 2009, 53:59-69.
35. Chang IH, Han JH, Myung SC, et al. Association between metabolic syndrome and chronic kidney disease in the Korean population. Nephrology (Carlton) 2009, 14:321-326.
36. Reynolds K, Gu D, Muntner P, et al. Body mass index and risk of ESRD in China. Am J Kidney Dis 2007, 50:754-764.
37. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004, 65:1870-1876.
38. Pinto-Sietsma SJ, Navis G, Janssen WM, et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003, 41:733-741.
39. Morales E, Valero MA, Leon M, Hernandez E, Praga M Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003, 41:319-327.
40. Coward RJ, Welsh GI, Koziell A, et al. Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes 2007, 56:1127-1135.
41. See LC, Kuo CF, Chuang FH, et al. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate. J Rheumatol 2009, 36:1691-1698.
42. Ford ES, Li C, Cook S, Choi HK Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007, 115:2526-2532.
43. Hernandez-Cuevas CB, Roque LH, Huerta-Sil G, et al. First acute gout attacks commonly precede features of the metabolic syndrome. J Clin Rheumatol 2009, 15:65-67.
44. Abrass CK Lipid metabolism and renal disease. Contrib Nephrol 2006, 151:106-121.
45. Kume S, Uzu T, Araki S, et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J Am Soc Nephrol 2007, 18:2715-2723.
46. Deji N, Kume S, Araki S, et al. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol 2009, 296:F118-F126.
47. Cirillo P, Gersch MS, Mu W, et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 2009, 20:545-553.
48. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000, 278:F817-F822.
49. Cohen AH Massive obesity and the kidney. A morphologic and statistical study. Am J Pathol 1975, 81:117-130.
50. Gersch MS, Mu W, Cirillo P, et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 2007, 293:F1256-F1261.
51. Souraty P, Nast CC, Mehrotra R, et al. Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetes. Nat Clin Pract Nephrol 2008, 4:639-642.
52. Alexander MP, Patel TV, Farag YM, et al. Kidney pathological changes in metabolic syndrome: a cross-sectional study. Am J Kidney Dis 2009, 53:751-759.
53. Sarafidis PA, Ruilope LM Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006, 26:232-244.
54. Sarafidis PA, Lasaridis AN Insulin resistance and endothelin: another pathway for renal injury in patients with the cardiometabolic syndrome?. J Cardiometab Syndr 2008, 3:183-187.
55. Ruan X, Zheng F, Guan Y PPARs and the kidney in metabolic syndrome. Am J Physiol Renal Physiol 2008, 294:F1032-F1047.